1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Glyoxalase (GLO)
  4. Glyoxalase (GLO) Inhibitor

Glyoxalase (GLO) Inhibitor

Glyoxalase (GLO) Inhibitors (22):

Cat. No. Product Name Effect Purity
  • HY-136684
    BrBzGCp2
    Inhibitor 99.00%
    BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activity.
  • HY-15167A
    Glyoxalase I inhibitor free base
    Inhibitor 98.52%
    Glyoxalase I inhibitor free base (3(Et)2) is the inhibitor for glyoxalase I (GLO), and can be used in antitumor research.
  • HY-W009177
    S-Methylglutathione
    Inhibitor 99.40%
    S-Methylglutathione is an S-substitued glutathione and a stronger nucleophile than GSH. S-Methylglutathione has inhibitory effect on glyoxalase 1.
  • HY-P4277
    N,S-Bis-Fmoc-Glutathione
    Inhibitor 99.45%
    N,S-Bis-Fmoc-Glutathione is a potent glyoxalase II inhibitor with a Ki value of 0.75 μM and an IC50 of 2.5 μM.
  • HY-117208
    TLSC702
    Inhibitor
    TLSC702 is a human glyoxalase I (hGLO I) inhibitor with an IC50 of 2.0 μM. TLSC702 inhibits the activity of human glyoxalase I, thereby leading to the accumulation of methylglyoxal and its derived advanced glycation end products. TLSC702 inhibits tumor cell proliferation, induces apoptotic morphological changes, internucleosomal DNA fragmentation and PARP cleavage in tumor cells. TLSC702 can be used in research related to leukemia and lung cancer.
  • HY-W842446
    Enzyme-IN-4
    Inhibitor
    Enzyme-IN-4 is a competitive inhibitor of glyoxalase I that can be found in Stereum hirsutum. Enzyme-IN-4 has a Ki value of 4.6 μM against rat liver glyoxalase I.
  • HY-P4277A
    N,S-Bis-Fmoc-Glutathione TFA
    Inhibitor
    N,S-Bis-Fmoc-Glutathione TFA is a potent glyoxalase II inhibitor with a Ki value of 0.75 μM and an IC50 of 2.5 μM.
  • HY-34005
    2-Dimethylaminophenol
    Inhibitor
    2-Dimethylaminophenol is an inhibitor of human glyoxalase 1 (GLO1). 2-Dimethylaminophenol disrupts metal binding by substituting the pyridine nitrogen donor with a dimethylamino group.
  • HY-146655
    Glyoxalase I inhibitor 3
    Inhibitor 98.06%
    Glyoxalase I inhibitor 3 (compound 22g) is a potent glyoxalase I (GLO1) inhibitor with an IC50 of 0.011 µM. Glyoxalase I inhibitor 3 has the potential for the research of depression and anxiety.
  • HY-15167
    Glyoxalase I inhibitor
    Inhibitor ≥98.0%
    Glyoxalase I inhibitor (3(Et)2) is the inhibitor for glyoxalase I (GLO), and can be used in antitumor research.
  • HY-147648
    Glyoxalase I inhibitor 6
    Inhibitor 99.26%
    Glyoxalase I inhibitor 6 (Compound 9j) is a glyoxalase I (Glo-I) inhibitor with an IC50 of 1.13 μM. Glyoxalase I inhibitor 6 can be used as anticancer agent with low toxicity.
  • HY-115915
    TS010
    Inhibitor
    TS010 is a potent inhibitor of GLO-I with IC50 of 0.57 μM. TS010 has the potential for the research of cancer disease.
  • HY-147649
    Glyoxalase I inhibitor 7
    Inhibitor
    Glyoxalase I inhibitor 7 (Compound 6) is a glyoxalase I (Glo-I) inhibitor with an IC50 of 3.65 μM. Glyoxalase I inhibitor 7 can be used as anticancer agent.
  • HY-153154
    COMC-6
    Inhibitor
    COMC-6 is an anticancer agent and can be used for study of cancer.
  • HY-146656
    Glyoxalase I inhibitor 4
    Inhibitor
    Glyoxalase I inhibitor 4 (compound 14) is a potent glyoxalase I inhibitor with an Ki of 10 nM.
  • HY-146653
    Glyoxalase I inhibitor 1
    Inhibitor
    Glyoxalase I inhibitor 1 (compound 23) is a potent glyoxalase I (GLO1) inhibitor with an IC50 of 26 nM. Glyoxalase I inhibitor 1 is a click chemistry reagent, itcontains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • HY-146654
    Glyoxalase I inhibitor 2
    Inhibitor
    Glyoxalase I inhibitor 2 (compound 26) is a potent glyoxalase I (GLO1) inhibitor with an IC50 of 0.5 µM. Glyoxalase I inhibitor 2 has the potential for the research of depression and anxiety.
  • HY-N12255
    COTC
    Inhibitor
    COTC is a bacterial metabolite with anticancer activity that is found in S. griseosporeus. COTC inhibits glyoxalase in the presence of glutathione (GSH). COTC also inhibits the proliferation of HeLa cells (IC50 = 18 µg/mL), as well as reduces tumor growth and improves survival in an Ehrlich murine spontaneous adenocarcinoma model.
  • HY-181980
    SPB07393SC
    Inhibitor
    SPB07393SC is a glyoxalase-I (Glo-I) inhibitor with an IC50 of 11.1 μM. SPB07393SC is applicable for cancer research.
  • HY-124824
    Methyl gerfelin
    Inhibitor 99.9%
    Methyl gerfelin inhibits osteoclast differentiation by binding 3 major cellular proteins: glyoxalase 1 (GLO1), sterol binding protein 2 (SCP2), and small glutamine-rich tetratricopeptide repeat containing protein A (SGTA). Methyl gerfelin is a potent GLO1 inhibitor related to the flavonoid class.